NVCT
Nuvectis Pharma, Inc. · Healthcare
Director Matthew L. Kaplan bought $51K of Nuvectis Pharma, Inc.
Bought$50,633
$16.88Price
3,000Shares
+9%Stake
What NVCT did for a copier
- $1,000 copied at Mon, May 16 open, $19.25
- $615
- S&P 500, same days
- −4.5%
Measured over 30 trading days, to the Jun 29 close.
Matthew L. Kaplan's record
1 other buy on record. A record shows here once 3 of them have 3 months of prices.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Thu, May 12. Filed Mon, May 16, 4:32 AM ET, before the open. Returns use the May 16 open and the Jun 29 close. Not investment advice.